APA

Zirakzadeh A. A., Kinn J., Krantz D., Rosenblatt R., Winerdal M. E., Hu J., Hartana C. A., Lundgren C., Bergman E. A., Johansson M., Holmström B., Hansson J., Sidikii A., Vasko J., Marits P., Sherif A. & Winqvist O. (20170605). Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer. : Clinical immunology (Orlando, Fla.).

Chicago

Zirakzadeh A Ali, Kinn Johan, Krantz David, Rosenblatt Robert, Winerdal Malin E, Hu Jin, Hartana Ciputra Adijaya, Lundgren Christian, Bergman Emma Ahlén, Johansson Markus, Holmström Benny, Hansson Johan, Sidikii Alexander, Vasko Janos, Marits Per, Sherif Amir and Winqvist Ola. 20170605. Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer. : Clinical immunology (Orlando, Fla.).

Harvard

Zirakzadeh A. A., Kinn J., Krantz D., Rosenblatt R., Winerdal M. E., Hu J., Hartana C. A., Lundgren C., Bergman E. A., Johansson M., Holmström B., Hansson J., Sidikii A., Vasko J., Marits P., Sherif A. and Winqvist O. (20170605). Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer. : Clinical immunology (Orlando, Fla.).

MLA

Zirakzadeh A Ali, Kinn Johan, Krantz David, Rosenblatt Robert, Winerdal Malin E, Hu Jin, Hartana Ciputra Adijaya, Lundgren Christian, Bergman Emma Ahlén, Johansson Markus, Holmström Benny, Hansson Johan, Sidikii Alexander, Vasko Janos, Marits Per, Sherif Amir and Winqvist Ola. Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer. : Clinical immunology (Orlando, Fla.). 20170605.